ABSTRACT Three 49-d experiments, with a total of 6,528 male broiler chicks in floor pens, were conducted to test the hypothesis that Semduramicin feeding-time affects the body weight gain, feed consumption, and feed conversion ratio of broilers. Semduramicin ionophore was added to corn and soybean meal-based diets at the recommended level, 25 mg/kg for 0, 34, 39, or 42 d. Thus, three withdrawal times were employed (7, 10, and 15 d) during each experiment. Significant differences among
INTRODUCTION
Ionophores have been widely used in broiler diets for more than 25 yr because they are effective anticoccidials against Eimeria species that infect chickens. Growth may or may not be depressed by feeding some ionophore anticoccidials (Frigg and Broz, 1983; Leeson and Summers, 1983; Morrison et al., 1979; Patel et al., 1980; Chapman et al., 1993) . When growth depression does occur, leaving the ionophore out of the diet for several days typically results in compensatory performance (McDougald and McQuistion, 1980; Metzler et al., 1987) . Thus, the introduction of a new ionophorus anticoccidial, Semduramicin, raises questions about the possibility of growth depression, performance compensation, and appropriate withdrawal times.
Three 49-d experiments were conducted to test the hypothesis that Semduramicin feeding time (at the recommended level, 25 mg/kg) affects body weight gain, feed consumption, and feed conversion ratio of broilers. To whom correspondence should be addressed: gpesti@ arches.uga.edu. 3 Aviax, Pfizer Animal Health, Exton, PA 19341. 4 Harrison Poultry, Bethlehem, GA 30620. 939 experiments were observed for body weight gain, feed intake, and feed conversion ratio, but no significant differences due to Semduramicin were noted in body weight or feed intake. There was only one treatment by experiment interaction found for 0-to-34-d feed intake (P = 0.028), but it was not evident for 0 to 39 d (P = 0.818) or any other times. Feeding Semduramicin with a 10-or 15-d withdrawal period resulted in an improvement in feed conversion of about 0.04 units.
MATERIALS AND METHODS
After thorough cleaning and disinfecting, the experimental houses were dried, litter was added (approximately six inches of wood shavings), and the buildings were heated to 40 C for 2 d to minimize coccidial challenge to the chicks. After this time, the buildings were only accessible by personnel wearing clean coveralls and disposable plastic boots. During the first 3 d, the bird level temperature was 33 C; each week afterwards the temperature was reduced 3 C until 23 C was reached. The facility was divided into four blocks (randomized complete block design). Treatments were assigned to pens (12 replicates) within block at random. Chicks from each hatchery box were randomly distributed across each block. The chicks were maintained on a 24-h light schedule, and feed and water were provided ad libitum. Chicks were vaccinated at the hatchery for Marek's disease, Newcastle disease, and infectious bronchitis.
Each experiment had an unmedicated control group and three treatments with added Semduramicin 3 (25 mg/ kg) for different times (34, 39, or 42 d); thus, three different withdrawal times were employed (10, 15, and 7 d). The birds and feed were weighed at 0, 18, 34, 39, and 49 d. From 0 to 18 d, birds were fed the starter diets; from 18 to 34 d; birds were fed grower diets; and from 34 to 49 d, birds were fed finisher diets (Table 1) .
For Experiments 1 and 2, Avian × Arbor Acre 1-dold male broiler chicks (2,208) for each experiment) were obtained from a commercial hatchery 4 and placed in 48 floor pens (46 chicks each per pen). In Experiment 3, 1-d- Vitamin premix provided the following per kilogram: vitamin A, 5,500 IU from all trans-retinyl acetate, cholecalciferol, 1,100 IU; vitamin E, 11 IU from all-rac-α-tocopherol acetate; riboflavin, 4.4 mg; Ca pantothenate, 12 mg; nicotinic acid, 44 mg; choline Cl, 220 mg; vitamin B 12 , 6.6 µg; vitamin B 6 , 2.2 mg; menadione, 1.1 mg (as menadione sodium bisulfate complex); folic acid, 0.55 mg; d-biotin, 0.11 mg; thiamine, 1.1 mg (as thiamine mononitrate); ethoxyquin, 125 mg. The results from all three experiments were analyzed as 1) one-way analysis using the general linear models (GLM) procedure of SAS software (SAS Institute, 1985) with means separation by Duncan's new multiple range test (Steel and Torrie, 1980) , and 2) split-plot randomized complete block design with main-effect means separation by Duncan's new multiple range test. When no significant (P > 0.05) treatment by experiment interactions or block effects were found, data were pooled for analyses and 5 Seaboard Farms, Athens, GA 30601. only main effect means are displayed. When a significant difference was detected for feed conversion (feed consumption per body weight gain) but not for feed consumption or body weight gain, analysis of covariance was conducted for feed consumption as a function of treatment and body weight gain. We tested for the heterogeneity of regression slopes of feed consumption versus body weight gain, found no significant differences (P ≥ 0.410), and removed that from the experimental model.
A 500-g sample of each feed was taken for analysis. The samples were assayed for Na and K 6 by atomic absorption spectroscopy and Cl 7 by silver chloride titration and colorimetry prior to diet formulation using Association of Official Analytical Chemists (AOAC, 1970) procedures. Protein and ether extract were measured by Association of Official Analytical Chemists (AOAC, 1990) procedures for proximate analysis, calcium was analyzed by the method of Hill (1955) , and phosphorus was measured by the method of O'Neill and Webb (1970). 
RESULTS AND DISCUSSION
This series of experiments was conducted to evaluate the intrinsic effects of the anticoccidial Semduramicin on performance of growing broilers, and as such, extensive measures were taken to raise these flocks of birds in the absence of coccidial infections. In this environment, the absolute performance (body weight gain, feed consumption, feed conversion ratio, and mortality) of the broilers in the three experiments was significantly different (P ≤ 0.003). Most of the variation among the experiments was due to different genetic stocks and the season in which the experiments were conducted. In addition, mortality in Experiment 1 was elevated because of an outbreak of necrotic enteritis (no concurrent coccidial infections were observed), but it was minimal in the other experiments. There were no significant treatment by experiment interactions, except for feed consumption from hatching to 34 d of age (P = 0.028). This response was attributable to the variation mentioned above, and because it was not manifested in a significant interaction for feed conversion ratio, all data were pooled for presentation in Tables 2 to 4 . When each experiment was analyzed separately, no significant treatment effects were found. Similarly, when the data were pooled across experiments (Tables 2 to 5) , no significant changes in body gain during any interval were noted. This finding is different from those of McDougald and McQuistion (1980) who reported reductions in feed intake with monensin that resulted in compensatory body gain after the product was withdrawn. In the current studies, feed intake tended to be lower for Semduramicin treatments with longer withdrawal periods (P = 0.191 for 15 d and P = 0.057 for 10 d). However, these same treatments were found to improve feed conversion ratios (P = 0.044 for 15 d withdrawal and P = 0.013 for 10 d withdrawal) from 0 to 49 d. Thus, Semdura- micin did not affect body gain, produced only subtle changes in feed intake, and significantly improved feed conversion ratio. When feeding Semduramicin across all withdrawal times was compared to the nonmedicated controls, the advantage was about 0.03 feed conversion ratio units. The 0.03-to 0.04-unit improvements from feeding Semduramicin observed in these tests are similar in magnitude to those demonstrated by Davami et al. (1987) for monensin and by Radu et al. (1987) for salinomycin and maduramicin. As mentioned above, studies of this type are usually conducted in the absence of imposed coccidial infection; the adverse effects of these parasites on performance are well documented. Accordingly, performance responses may be positively or negatively affected depending on the nature and severity of the coccidial challenge or the ionophore in use at a particular time. In addition, no other antibiotic was fed in any of the trials, so it remains to be determined if the feed saving effects would result if the anticoccidials were fed in combination with growth promoting levels of a broad-spectrum antibiotic.
Results like those in Tables 3 and 4 raise questions of the appropriate statistical model to evaluate such data. For 0 to 49 d, there is no significant difference in body weight gain (P = 0.968) or feed consumption (P = 0.137), but there is in feed conversion ratio (feed:gain ratio; P = 0.031). The problem is that variation among pens in body gains not related to treatment effects results in variation in consumption. When the among-pen variation in gain is not accounted for when analyzing consumption data as in Table 3 , the chances of not declaring significant differences is increased. By considering variation in consumption and gain together as a ratio as in Table 4 , more variation is accounted for and the chance of declaring significant differences is increased. An alternative analysis with feed consumption as a function of treatment and experiment with body weight gain as a covariant is presented in Table 6 . From this analysis of covariance, it is clear that there are differences in consumption from feeding Semduramicin. However, they may not be declared significant unless variability from body weight gain is accounted for in the model. Pens of birds that are growing faster (for whatever reason) naturally eat more feed, which increases apparent variation in consumption and makes differences harder to declare significant. This project was undertaken in the hope that the results would be applicable to practical farming. To be of use, the conclusions drawn from such research must be valid for different conditions, such as genetic stocks, feed ingredient batches, and environmental conditions such as temperature and litter source, etc. Neither researchers nor farmers are practically able to perfectly control a number of factors that may affect the performance of their birds. We may be able to do a fair job of controlling temperature, but we can still expect some differences in growth rate due to season or temperature. We are never sure of the cultivar of the corn and soybean meal used, or where they were grown or processed, or the litter source and condition, or the disease challenge, etc. We need to know if consistent differences due to treatment can be expected across experiments in spite of all the differences from other potential sources. If consistent differences due to treatment are found across several experiments, then we can feel more confident that the research will be valid across a range of commercial conditions.
In analyzing the results of a series of experiments, as in Tables 2 to 5, the power of the analysis is increased by increasing error degrees of freedom (compared to analyzing each experiment separately), but variation is also introduced into the model that increases the possibility of not declaring significant differences when they do, indeed, exist.
We know a priori that differences among experiments should exist, and they were indeed found to be significant. But the important questions of interest in this series of experiments are 1) is there a treatment effect? and 2) are the differences among treatments the same in all the experiments? Or should we consider recommending different treatments for different circumstances? It is necessary to analyze the experiments as a series to find the probability that there is a treatment by experiment interaction (Cochran and Cox, 1957) . Cochran and Cox (1957) pointed out that there are two main criticisms that may be made of analyzing agricultural experiments as a series, such as experiments run in different soil types and during different years, and the ones reported here. There may be heterogeneity of the interaction variance, and there may be heterogeneity of the experimental error variances. Both of these variances were found to be homogeneous for all variables in all three experiments reported here. Therefore, these criticisms do not apply to the present analyses, and there is no reason to consider recommending different treatments for different circumstances, from these experiments.
The null hypothesis of these experiments, that Semduramicin does not affect body weight, must be accepted. There is evidence from the analysis of covariance that feed consumption was reduced, explaining the improvement in feed conversion ratio. This result was especially true for the longer withdrawal periods.
